Antitumor Activity, Mechanisms of Action and Phytochemical Profiling of Sub-Fractions Obtained from Ulex gallii Planch. (Fabaceae): A Medicinal Plant from Galicia (Spain)
Molecules,
Journal Year:
2025,
Volume and Issue:
30(4), P. 972 - 972
Published: Feb. 19, 2025
The
plant
kingdom
serves
as
a
valuable
resource
for
cancer
drug
development.
This
study
explored
the
antitumor
activity
of
different
sub-fractions
(hexane,
dichloromethane
and
methanol)
U.
gallii
(gorse)
methanol
extract
in
glioblastoma
(U-87MG
U-373MG)
neuroblastoma
(SH-SY5Y)
cell
lines,
along
with
their
phytochemical
profiles.
Cytotoxicity
was
evaluated
using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide
(MTT)
lactate
dehydrogenase
(LDH)
assays,
cycle
arrest
apoptosis
were
assessed
through
flow
cytometry
by
measuring
reactive
oxygen
species
(ROS)
protein
expression
levels.
D7
D8
significantly
reduced
viability,
triggered
early
SH-SY5Y
U-87MG
cells
specifically
increased
ROS
levels
cells.
Western
blot
analyses
showed
that
p53,
caspase-3,
caspase-8
γH2AX
cells,
while
elevated
p53
caspase-3
both
lines.
In
U-373
markedly
inducing
necrosis.
Morphological
changes
indicative
also
observed
all
Bioinformatic
analysis
UHPLC-MS
GC-MS
data
tentatively
identified
20
metabolites
15
D8,
primarily
flavonoids.
HPLC-DAD
confirmed
isoprunetin
genistein
most
abundant
respectively,
isolated
NMR
spectroscopy.
Most
flavonoids
have
been
reported
agents,
suggesting
these
compounds
may
be
responsible
pharmacological
activity.
Language: Английский
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu,
No information about this author
Jin Wang,
No information about this author
Lei Hu
No information about this author
et al.
Chinese Chemical Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 110995 - 110995
Published: Feb. 1, 2025
Language: Английский
FAPI-avid Lesions in the Brain
Nasrin Raeisi,
No information about this author
Amin Saber Tanha,
No information about this author
Farid Jafari Zarrin Ghabaei
No information about this author
et al.
Clinical Nuclear Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 18, 2025
A
63-year-old
man
presented
with
transient
global
amnesia,
urinary
incontinence,
and
a
visual
field
deficit.
MRI
revealed
heterogeneous
mass
in
the
left
parieto-occipital
lobe,
diagnosed
as
glioblastoma
multiforme
(GBM).
Following
craniotomy,
chemotherapy
temozolomide
radiotherapy
were
initiated.
Two
months
after
radiotherapy,
indicated
possible
tumor
recurrence,
leading
to
change
treatment.
Despite
further
interventions,
patient
exhibited
new-appearing
symptoms
significant
increase
size.
99m
Tc-FAPI-46
scintigraphy
showed
avidity
tumoral
recurrence.
This
case
highlights
potential
of
this
novel,
low-cost
imaging
technique
for
assessing
eligibility
radio-ligand
therapy
resource-limited
countries.
Language: Английский